--- title: "Innoviva (INVA) stock listing, news and investor profile" url: "https://aibio.space/companies/innoviva/" publisher: "aibio.space (Biotech Investor Relations News)" summary: "Innoviva, Inc. (NASDAQ: INVA), United States. The directory classifies it as Pharmaceuticals: Major." --- INVA Innoviva, Inc. NASDAQ · United States # Innoviva (INVA) news Debt Financing · 2025-03-12 ## [Armata Pharmaceuticals signs $10 million loan from largest holder Innoviva at 14.0%](https://aibio.space/news/armata-pharmaceuticals-signs-10-million-loan-largest-holder-innoviva/) The secured term loan matures on March 12, 2026. Armata also pushed back the maturity of three earlier Innoviva credit agreements to the same date. ## Latest Innoviva news We have not published a story on Innoviva yet. When there is news, it will appear here. ## Innoviva at a glance - **Ticker**: INVA - **Listing**: NASDAQ - **Country**: United States - **Cash, Jun 30, 2026**: $570.4 million ### Related companies - [Neuphoria Therapeutics](https://aibio.space/companies/neuphoria-therapeutics/) NASDAQ: NEUP - [Artelo Biosciences](https://aibio.space/companies/artelo-biosciences/) NASDAQ: ARTL - [Lyra Therapeutics](https://aibio.space/companies/lyra-therapeutics/) OTC: LYRA - [REGENXBIO](https://aibio.space/companies/regenxbio/) NASDAQ: RGNX - [Actuate Therapeutics](https://aibio.space/companies/actuate-therapeutics/) NASDAQ: ACTU - [Panbela Therapeutics](https://aibio.space/companies/panbela-therapeutics/) OTC: PBLA - [Biohaven](https://aibio.space/companies/biohaven/) NYSE: BHVN - [Parabilis Medicines](https://aibio.space/companies/parabilis-medicines/) NASDAQ: PBLS ### Also on NASDAQ - [Soligenix](https://aibio.space/companies/soligenix/) SNGX - [Cellectar Biosciences](https://aibio.space/companies/cellectar-biosciences/) CLRB - [Corvus Pharmaceuticals](https://aibio.space/companies/corvus-pharmaceuticals/) CRVS - [Kiniksa Pharmaceuticals International](https://aibio.space/companies/kiniksa-pharmaceuticals-international/) KNSA - [Prime Medicine](https://aibio.space/companies/prime-medicine/) PRME - [Beam Therapeutics](https://aibio.space/companies/beam-therapeutics/) BEAM ## Innoviva annual financials | Line | FY2025 | FY2024 | |---|---|---| | Research and development | [$30.6 million](https://www.sec.gov/Archives/edgar/data/1080014/000119312526071776/) | [$13.7 million](https://www.sec.gov/Archives/edgar/data/1080014/000119312526071776/) | | Net income (loss) | [$271.2 million](https://www.sec.gov/Archives/edgar/data/1080014/000119312526071776/) | [$23.4 million](https://www.sec.gov/Archives/edgar/data/1080014/000119312526071776/) | | Cash from operations | [$196.9 million](https://www.sec.gov/Archives/edgar/data/1080014/000119312526071776/) | [$188.7 million](https://www.sec.gov/Archives/edgar/data/1080014/000119312526071776/) | | Cash and equivalents | [$550.9 million](https://www.sec.gov/Archives/edgar/data/1080014/000119312526335235/) | [$305.0 million](https://www.sec.gov/Archives/edgar/data/1080014/000119312526071776/) | Latest balance sheet, Jun 30, 2026 (10-Q): cash and equivalents $570.4 million. Figures as reported to the SEC in XBRL; each one links to its filing. Not adjusted, not investment advice. ## Questions about Innoviva What is the ticker symbol of Innoviva? Innoviva, Inc. trades under the ticker INVA on NASDAQ. Where is Innoviva listed? Innoviva, Inc. is listed on NASDAQ. Our directory also records these other listings: GETTEX:HVE; LS:A2AC9U; LSX:A2AC9U. What is the SEC CIK of Innoviva? The SEC Central Index Key (CIK) for Innoviva, Inc. is 1080014. Its filings are on SEC EDGAR. How many shares does Innoviva have outstanding? 72,245,485 shares as of 2026-07-31, per the cover page of its 10-Q filed 2026-08-05. Which country or territory is Innoviva listed under? Our directory records Innoviva, Inc. under United States. What does Innoviva do? Our directory classifies Innoviva, Inc. as: Pharmaceuticals: Major. This is a directory classification, not a description of the pipeline. What is the ISIN of Innoviva? The ISIN recorded for Innoviva, Inc. is US45781M1018. Does aibio.space cover Innoviva? aibio.space lists Innoviva, Inc. among 2,820 public biotech companies and publishes its news here as stories appear. Where is Innoviva incorporated? SEC records list its state or country of incorporation as DE. Is Innoviva profitable? Innoviva, Inc. reported net income of $271.2 million for the fiscal year ended Dec 31, 2025, and generated $196.9 million of cash from operations, per its annual report to the SEC. How much does Innoviva spend on research and development? $30.6 million in the fiscal year ended Dec 31, 2025, per its annual report. How much cash does Innoviva have? $570.4 million in cash at Jun 30, 2026, per its 10-Q. What is Innoviva's market cap? We do not publish live share prices. In its annual report, Innoviva, Inc. put the market value of shares held by non-affiliates (public float) at $1.26 billion as of Jun 30, 2025. Is Innoviva a smaller reporting company? SEC records list Innoviva, Inc.'s filer category as: Large accelerated filer. Where is Innoviva headquartered? SEC records list its business address as 1350 OLD BAYSHORE HIGHWAY, BURLINGAME, CA, 94010. ## Investor discussion: Innoviva Members talk about Innoviva (INVA). Reader posts, not aibio.space reporting, and not investment advice. Rules 1. **Securities violations are strictly forbidden.** No market manipulation, no pump-and-dump, no false or misleading statements, and no inside information. 2. **Say whether you hold the stock.** Every post states long, short or no position. 3. **No paid or sponsored posts.** Do not post for anyone who pays or rewards you. 4. **No buy or sell calls and no price targets.** 5. **No accusations of crime or fraud against named people** unless you link a court filing or a regulator's release that makes them. 6. **No personal details and no spam.** No links at all for your first 7 days as a member. Posts that break the rules may be deleted without notice, and the account restricted or closed. See the [terms](https://aibio.space/terms/#discussion) and the [privacy policy](https://aibio.space/privacy/#discussion). ## Stock chart Price chart and quote supplied by TradingView, delayed as the exchange requires. It loads only if you choose to show it. Information only, not investment advice. [Open NASDAQ:INVA on TradingView](https://www.tradingview.com/symbols/NASDAQ-INVA/). ## SEC filings and registration - **SEC name**: Innoviva, Inc. - **CIK**: 1080014 - **Industry (SIC)**: Pharmaceutical Preparations (2834) - **US tickers**: INVA (Nasdaq) - **State or country of incorporation**: DE - **Fiscal year ends**: December 31 - **Filer category**: Large accelerated filer - **Business address**: 1350 OLD BAYSHORE HIGHWAY, BURLINGAME, CA, 94010 - **Phone**: 6502389600 - **Shares outstanding**: 72,245,485 as of 2026-07-31 (10-Q filed 2026-08-05) - **Former names**: THERAVANCE INC; ADVANCED MEDICINE INC ### Recent filings (8-K and 6-K are the company's own announcements) - [10-Q](https://www.sec.gov/Archives/edgar/data/1080014/000119312526335235/inva-20260630.htm) filed 2026-08-05 - [8-K](https://www.sec.gov/Archives/edgar/data/1080014/000119312526335192/d228097d8k.htm) filed 2026-08-05 - [8-K](https://www.sec.gov/Archives/edgar/data/1080014/000119312526228958/d480193d8k.htm) filed 2026-05-18 - [10-Q](https://www.sec.gov/Archives/edgar/data/1080014/000119312526209110/inva-20260331.htm) filed 2026-05-06 - [8-K](https://www.sec.gov/Archives/edgar/data/1080014/000119312526209044/d54063d8k.htm) filed 2026-05-06 - [8-K](https://www.sec.gov/Archives/edgar/data/1080014/000119312526204243/d115579d8k.htm) filed 2026-05-04 - [DEF 14A](https://www.sec.gov/Archives/edgar/data/1080014/000114036126010912/ef20068585_def14a.htm) filed 2026-03-24 - [8-K](https://www.sec.gov/Archives/edgar/data/1080014/000119312526071974/d23292d8k.htm) filed 2026-02-25 Source: [SEC EDGAR](https://www.sec.gov/cgi-bin/browse-edgar?action=getcompany&CIK=0001080014), retrieved October 23, 2026. Shares outstanding is the cover-page figure from the latest periodic report. The SEC does not publish share prices. ## Listing details Innoviva, Inc. is a public biotech or pharmaceutical company listed on NASDAQ under the ticker INVA, recorded under United States. The directory classifies it as Pharmaceuticals: Major. aibio.space tracks 2,820 public biotech companies worldwide and publishes investor news on them. - **Company**: Innoviva, Inc. - **Ticker**: INVA - **Listing**: NASDAQ - **Country or territory**: United States - **Business scope**: Pharmaceuticals: Major - **ISIN**: US45781M1018 - **Other listed symbols**: GETTEX:HVE; LS:A2AC9U; LSX:A2AC9U - **Last quote in directory**: 2026-10-21 - **Directory source**: [Listing page](https://www.tradingview.com/symbols/NASDAQ-INVA/) Listing facts come from our company directory, researched on October 22, 2026. A listing record does not certify that a security currently trades. [Tell us about a change](https://aibio.space/reputation/#update). Work at this company? [Claim this page](https://aibio.space/claim/). Published and maintained by aibio.space. Not investment advice. [How we work](https://aibio.space/disclosures/). Who manages this page **This page is managed by aibio.space.** The company does not run, edit or pay for this page. News, desk views and Investor Ranks are written and managed independently by aibio.space under our editorial and analytical judgment. Opinion only, not investment advice. [How we work](https://aibio.space/disclosures/#paid) · [Terms](https://aibio.space/terms/#news) · [Request a correction](https://aibio.space/reputation/#update) --- Source page: https://aibio.space/companies/innoviva/. Facts in aibio.space stories are checked against company filings and releases; opinion is labelled. Cite as: aibio.space, "Innoviva (INVA) stock listing, news and investor profile", 2026-10-31, https://aibio.space/companies/innoviva/